このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Amedisys バランスシートの健全性
財務の健全性 基準チェック /66
Amedisysの総株主資本は$1.1B 、総負債は$364.0Mで、負債比率は31.9%となります。総資産と総負債はそれぞれ$2.1Bと$947.2Mです。 Amedisysの EBIT は$202.3Mで、利息カバレッジ比率7.4です。現金および短期投資は$108.2Mです。
主要情報
31.9%
負債資本比率
US$364.01m
負債
| インタレスト・カバレッジ・レシオ | 7.4x |
| 現金 | US$108.23m |
| エクイティ | US$1.14b |
| 負債合計 | US$947.22m |
| 総資産 | US$2.09b |
財務の健全性に関する最新情報
Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25
We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Recent updates
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?
Apr 10Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around
Feb 10At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jan 03A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Dec 16Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal
Nov 12Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?
Sep 19An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued
Sep 04Amedisys: ROIC, Tangible Book Value Each Softening
Aug 24Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement
Aug 04Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates
Jul 27We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jun 04Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled
May 05Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?
Apr 20Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?
Apr 06Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue
Jan 19Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
Dec 03These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Jul 23Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity
Jul 18Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive
Jun 28It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package
Jun 02Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
May 24財務状況分析
短期負債: AMEDの 短期資産 ( $526.4M ) が 短期負債 ( $484.9M ) を超えています。
長期負債: AMEDの短期資産 ( $526.4M ) が 長期負債 ( $462.4M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: AMEDの 純負債対資本比率 ( 22.4% ) は 満足できる 水準であると考えられます。
負債の削減: AMEDの負債対資本比率は、過去 5 年間で58.9%から31.9%に減少しました。
債務返済能力: AMEDの負債は 営業キャッシュフロー によって 十分にカバー されています ( 28.8% )。
インタレストカバレッジ: AMEDの負債に対する 利息支払い は EBIT ( 7.4 x coverage) によって 十分にカバーされています。